Inventor · disambiguated record
Scott Fields
Also filed as: FIELDS SCOTT · FIELDS SCOTT Z · FIELDS SCOTT ZACHARY
3 granted patents·9 pending applications·2 citations·filing 2004–2022
54Inventor score
Top patents by PatentIndex Score
12 records- 0182US7976852B2Compositions and methods for cancer immunotherapyEISAI R&D MAN CO LTD·Filed 2006·Granted Jul 12, 2011·2 cites·27 claims
- 0265US2023106592A1Method for treating cancer using a combination of dna damaging agents and atr inhibitorsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 0365US2014065100A1Compositions and Methods for Cancer ImmunotherapyEISAI R&D MAN CO LTD·Filed 2013·Application pending·0 cites
- 0462US2007292418A1Compositions and methods for immunotherapyEISAI CO LTD·Filed 2006·Application pending·0 cites
- 0560US2008070944A1Novel methods using aminobenzoic acid compoundsEISAI CO LTD·Filed 2007·Application pending·0 cites
- 0655US11464774B2Method for treating cancer using a combination of DNA damaging agents and ATR inhibitorsVERTEX PHARMA·Filed 2016·Granted Oct 11, 2022·0 cites·14 claims
- 0753US2004186127A1Novel deazapurines and uses thereofEISAI CO LTD·Filed 2004·Application pending·0 cites
- 0853US2009131480A1Dihydropyridine Compounds for Neurodegenerative Diseases and DementiaEISAI CO LTD·Filed 2006·Application pending·0 cites
- 0952US8603482B2Compositions and methods for cancer immunotherapyROSSIGNOL DANIEL P·Filed 2011·Granted Dec 10, 2013·0 cites·12 claims
- 1052US2011243935A1Compositions and Methods for ImmunotherapyEISAI R&D MAN CO LTD·Filed 2011·Application pending·0 cites
- 1152US2006270709A1Dihydropyridine compounds and compositions for headachesEISAI CO LTD·Filed 2006·Application pending·0 cites
- 1242US2007015789A1Novel methods using aminobenzoic acid compoundsBARTH JAY·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Fields files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →